Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9153209 | American Heart Journal | 2005 | 7 Pages |
Abstract
For elective PCI, adjunctive pharmacotherapy consisting of broad-spectrum antiplatelet therapy alone, without scheduled unfractionated heparin or other antithrombin therapy, appears to be safe and may prove to be efficacious.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Scott J. MD, Keith E. MD, James E. MD,